PCVX
Vaxcyte, Inc. - Common Stock (PCVX)
$30
About Vaxcyte, Inc. - Common Stock (PCVX)
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Details
Daily high
$60.54
Daily low
$57.62
Price at open
$59.78
52 Week High
$65.00
52 Week Low
$31.51
Market cap
8.7B
Dividend yield
-
Volume
683,025
Avg. volume
1.2M
P/E ratio
-7.54
Vaxcyte, Inc. - Common Stock News
Details
Daily high
$60.54
Daily low
$57.62
Price at open
$59.78
52 Week High
$65.00
52 Week Low
$31.51
Market cap
8.7B
Dividend yield
-
Volume
683,025
Avg. volume
1.2M
P/E ratio
-7.54